19 results
8-K
EX-10.1
ARVN
Arvinas Inc
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively
S-3ASR
EX-1.2
ARVN
Arvinas Inc
7 Nov 23
Automatic shelf registration
5:24pm
, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental Laws”), (ii) has received all permits, licenses or other
8-K
EX-1.1
oeq8p4xrsqifd
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.2
f332x4pb1 6prm
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-1.1
rsxvi
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
8-K
EX-1.1
7lk2 q4oib8gh
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm
8-K
EX-10.1
gmhdis
15 Mar 19
Entry into a Material Definitive Agreement
5:01pm
DRS
EX-10.11
cvqhxyhczgm 882j
22 Jun 18
Draft registration statement
12:00am
DRS
EX-10.6
3i5sjx8vzo3
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next